25 XP   0   0   10

Eris Lifesciences Ltd
Buy, Hold or Sell?

Let's analyse Eris together

PenkeI guess you are interested in Eris Lifesciences Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Eris Lifesciences Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Eris Lifesciences Ltd

I send you an email if I find something interesting about Eris Lifesciences Ltd.

Quick analysis of Eris (30 sec.)










What can you expect buying and holding a share of Eris? (30 sec.)

How much money do you get?

How much money do you get?
INR0.09
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
INR177.28
Expected worth in 1 year
INR205.56
How sure are you?
75.0%

+ What do you gain per year?

Total Gains per Share
INR35.62
Return On Investment
4.0%

For what price can you sell your share?

Current Price per Share
INR892.60
Expected price per share
INR825.00 - INR962.50
How sure are you?
50%

1. Valuation of Eris (5 min.)




Live pricePrice per Share (EOD)

INR892.60

2. Growth of Eris (5 min.)




Is Eris growing?

Current yearPrevious yearGrowGrow %
How rich?$289.3m$236.1m$28.7m10.9%

How much money is Eris making?

Current yearPrevious yearGrowGrow %
Making money$11.5m$12m-$469.1k-4.1%
Net Profit Margin21.3%26.2%--

How much money comes from the company's main activities?

3. Financial Health of Eris (5 min.)




What can you expect buying and holding a share of Eris? (5 min.)

Welcome investor! Eris's management wants to use your money to grow the business. In return you get a share of Eris.

What can you expect buying and holding a share of Eris?

First you should know what it really means to hold a share of Eris. And how you can make/lose money.

Speculation

The Price per Share of Eris is INR892.60. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Eris.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Eris, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR177.28. Based on the TTM, the Book Value Change Per Share is INR7.07 per quarter. Based on the YOY, the Book Value Change Per Share is INR11.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR1.84 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Eris.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.110.0%0.090.0%0.090.0%0.090.0%0.090.0%
Usd Book Value Change Per Share0.190.0%0.080.0%0.130.0%0.270.0%0.270.0%
Usd Dividend Per Share0.000.0%0.020.0%0.080.0%0.040.0%0.040.0%
Usd Total Gains Per Share0.190.0%0.110.0%0.210.0%0.310.0%0.310.0%
Usd Price Per Share10.52-8.38-8.40-8.34-8.34-
Price to Earnings Ratio24.16-25.12-24.64-25.21-25.21-
Price-to-Total Gains Ratio55.34-42.14-39.85-35.67-35.67-
Price to Book Ratio4.95-4.29-4.84-4.75-4.75-
Price-to-Total Gains Ratio55.34-42.14-39.85-35.67-35.67-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share10.7112
Number of shares93
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.04
Usd Book Value Change Per Share0.080.27
Usd Total Gains Per Share0.110.31
Gains per Quarter (93 shares)9.9428.46
Gains per Year (93 shares)39.75113.82
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1832301599104
216637030198218
3259511045297332
43312615060396446
54115819074495560
64918923089594674
757221270104692788
866252310119791902
9742843501348901016
10823163901499891130

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Book Value Change Per Share2.00.02.050.0%6.00.02.075.0%6.00.02.075.0%6.00.02.075.0%6.00.02.075.0%
Dividend per Share1.00.03.025.0%4.00.04.050.0%4.00.04.050.0%4.00.04.050.0%4.00.04.050.0%
Total Gains per Share2.00.02.050.0%6.00.02.075.0%6.00.02.075.0%6.00.02.075.0%6.00.02.075.0%

Fundamentals of Eris

About Eris Lifesciences Ltd

Eris Lifesciences Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of domestic branded formulations for chronic and sub-chronic therapies in India. The company offers various branded formulations in various therapeutic areas, such as anti"diabetes, anti-infective, blood related, cardiovascular, dermatology, gastrointestinal, gastroenterology, haematinics, hormones, nero/ central nervous system, neuropsychiatry, otologicals, pain/analgesics, respiratory, stomatologicals, cosmetology, women's health, and vitamins/minerals/nutrients. It also provides patient care services, including blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and ante-natal care solutions. The company offers its products through wholesale drug distributors, and stockiest and retail pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.

Fundamental data was last updated by Penke on 2024-04-10 13:03:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Eris Lifesciences Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Eris earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Eris to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 24.4% means that ₹0.24 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Eris Lifesciences Ltd:

  • The MRQ is 24.4%. The company is making a huge profit. +2
  • The TTM is 21.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ24.4%TTM21.3%+3.2%
TTM21.3%YOY26.2%-4.9%
TTM21.3%5Y24.4%-3.1%
5Y24.4%10Y24.4%0.0%
1.1.2. Return on Assets

Shows how efficient Eris is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Eris to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.2% Return on Assets means that Eris generated ₹0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Eris Lifesciences Ltd:

  • The MRQ is 3.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.2%TTM2.8%+0.4%
TTM2.8%YOY3.9%-1.1%
TTM2.8%5Y3.5%-0.8%
5Y3.5%10Y3.5%0.0%
1.1.3. Return on Equity

Shows how efficient Eris is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Eris to the Drug Manufacturers - Specialty & Generic industry mean.
  • 5.1% Return on Equity means Eris generated ₹0.05 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Eris Lifesciences Ltd:

  • The MRQ is 5.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 4.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ5.1%TTM4.4%+0.8%
TTM4.4%YOY5.1%-0.7%
TTM4.4%5Y4.8%-0.5%
5Y4.8%10Y4.8%0.0%

1.2. Operating Efficiency of Eris Lifesciences Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Eris is operating .

  • Measures how much profit Eris makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Eris to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Eris Lifesciences Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM18.6%-18.6%
TTM18.6%YOY13.3%+5.2%
TTM18.6%5Y12.6%+5.9%
5Y12.6%10Y12.6%0.0%
1.2.2. Operating Ratio

Measures how efficient Eris is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.90 means that the operating costs are ₹0.90 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Eris Lifesciences Ltd:

  • The MRQ is 0.903. The company is less efficient in keeping operating costs low.
  • The TTM is 0.920. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.903TTM0.920-0.018
TTM0.920YOY0.933-0.012
TTM0.9205Y0.823+0.097
5Y0.82310Y0.8230.000

1.3. Liquidity of Eris Lifesciences Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Eris is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.93 means the company has ₹1.93 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Eris Lifesciences Ltd:

  • The MRQ is 1.933. The company is able to pay all its short-term debts. +1
  • The TTM is 0.915. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ1.933TTM0.915+1.019
TTM0.915YOY2.426-1.512
TTM0.9155Y1.742-0.828
5Y1.74210Y1.7420.000
1.3.2. Quick Ratio

Measures if Eris is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Eris to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.12 means the company can pay off ₹1.12 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Eris Lifesciences Ltd:

  • The MRQ is 1.119. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 0.605. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.119TTM0.605+0.514
TTM0.605YOY1.881-1.277
TTM0.6055Y1.312-0.707
5Y1.31210Y1.3120.000

1.4. Solvency of Eris Lifesciences Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Eris assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Eris to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.38 means that Eris assets are financed with 37.8% credit (debt) and the remaining percentage (100% - 37.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Eris Lifesciences Ltd:

  • The MRQ is 0.378. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.368. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.378TTM0.368+0.009
TTM0.368YOY0.227+0.142
TTM0.3685Y0.278+0.090
5Y0.27810Y0.2780.000
1.4.2. Debt to Equity Ratio

Measures if Eris is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Eris to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 60.7% means that company has ₹0.61 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Eris Lifesciences Ltd:

  • The MRQ is 0.607. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.591. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.607TTM0.591+0.016
TTM0.591YOY0.303+0.288
TTM0.5915Y0.415+0.175
5Y0.41510Y0.4150.000

2. Market Valuation of Eris Lifesciences Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Eris generates.

  • Above 15 is considered overpriced but always compare Eris to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 24.16 means the investor is paying ₹24.16 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Eris Lifesciences Ltd:

  • The EOD is 24.593. Based on the earnings, the company is fair priced.
  • The MRQ is 24.164. Based on the earnings, the company is fair priced.
  • The TTM is 25.118. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD24.593MRQ24.164+0.428
MRQ24.164TTM25.118-0.954
TTM25.118YOY24.640+0.478
TTM25.1185Y25.214-0.096
5Y25.21410Y25.2140.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Eris Lifesciences Ltd:

  • The EOD is 15.853. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 15.577. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 2.997. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD15.853MRQ15.577+0.276
MRQ15.577TTM2.997+12.580
TTM2.997YOY-38.592+41.590
TTM2.9975Y-5.773+8.770
5Y-5.77310Y-5.7730.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Eris is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 4.95 means the investor is paying ₹4.95 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Eris Lifesciences Ltd:

  • The EOD is 5.035. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.947. Based on the equity, the company is fair priced.
  • The TTM is 4.286. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD5.035MRQ4.947+0.088
MRQ4.947TTM4.286+0.661
TTM4.286YOY4.841-0.555
TTM4.2865Y4.755-0.468
5Y4.75510Y4.7550.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Eris Lifesciences Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--15.8487.069+124%11.077+43%22.161-28%22.161-28%
Book Value Per Share--177.285162.292+9%144.648+23%147.651+20%147.651+20%
Current Ratio--1.9330.915+111%2.426-20%1.742+11%1.742+11%
Debt To Asset Ratio--0.3780.368+3%0.227+67%0.278+36%0.278+36%
Debt To Equity Ratio--0.6070.591+3%0.303+100%0.415+46%0.415+46%
Dividend Per Share---1.836-100%6.673-100%3.337-100%3.337-100%
Eps--9.0747.086+28%7.373+23%7.101+28%7.101+28%
Free Cash Flow Per Share--14.076-12.892+192%8.425+67%5.640+150%5.640+150%
Free Cash Flow To Equity Per Share--7.2959.008-19%10.099-28%11.418-36%11.418-36%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap121418592800.000+2%119303357400.00094962847150.000+26%95219600000.000+25%94491850200.000+26%94491850200.000+26%
Net Profit Margin--0.2440.213+15%0.262-7%0.244+0%0.244+0%
Operating Margin---0.186-100%0.133-100%0.126-100%0.126-100%
Operating Ratio--0.9030.920-2%0.933-3%0.823+10%0.823+10%
Pb Ratio5.035+2%4.9474.286+15%4.841+2%4.755+4%4.755+4%
Pe Ratio24.593+2%24.16425.118-4%24.640-2%25.214-4%25.214-4%
Price Per Share892.600+2%877.050698.113+26%700.000+25%694.650+26%694.650+26%
Price To Free Cash Flow Ratio15.853+2%15.5772.997+420%-38.592+348%-5.773+137%-5.773+137%
Price To Total Gains Ratio56.322+2%55.34142.136+31%39.852+39%35.667+55%35.667+55%
Quick Ratio--1.1190.605+85%1.881-41%1.312-15%1.312-15%
Return On Assets--0.0320.028+15%0.039-18%0.035-10%0.035-10%
Return On Equity--0.0510.044+17%0.051+1%0.048+6%0.048+6%
Total Gains Per Share--15.8488.905+78%17.751-11%25.497-38%25.497-38%
Usd Book Value--289388160.000264914430.000+9%236114880.000+23%241015860.000+20%241015860.000+20%
Usd Book Value Change Per Share--0.1900.085+124%0.133+43%0.266-28%0.266-28%
Usd Book Value Per Share--2.1271.947+9%1.736+23%1.772+20%1.772+20%
Usd Dividend Per Share---0.022-100%0.080-100%0.040-100%0.040-100%
Usd Eps--0.1090.085+28%0.088+23%0.085+28%0.085+28%
Usd Free Cash Flow--22976520.000-10521660.000+146%13752960.000+67%6904395.000+233%6904395.000+233%
Usd Free Cash Flow Per Share--0.169-0.155+192%0.101+67%0.068+150%0.068+150%
Usd Free Cash Flow To Equity Per Share--0.0880.108-19%0.121-28%0.137-36%0.137-36%
Usd Market Cap1457023113.600+2%1431640288.8001139554165.800+26%1142635200.000+25%1133902202.400+26%1133902202.400+26%
Usd Price Per Share10.711+2%10.5258.377+26%8.400+25%8.336+26%8.336+26%
Usd Profit--14811600.00011566860.000+28%12036000.000+23%11592030.000+28%11592030.000+28%
Usd Revenue--60635880.00053939310.000+12%45987360.000+32%48034635.000+26%48034635.000+26%
Usd Total Gains Per Share--0.1900.107+78%0.213-11%0.306-38%0.306-38%
 EOD+4 -4MRQTTM+25 -10YOY+19 -165Y+18 -1710Y+18 -17

3.2. Fundamental Score

Let's check the fundamental score of Eris Lifesciences Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1524.593
Price to Book Ratio (EOD)Between0-15.035
Net Profit Margin (MRQ)Greater than00.244
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.119
Current Ratio (MRQ)Greater than11.933
Debt to Asset Ratio (MRQ)Less than10.378
Debt to Equity Ratio (MRQ)Less than10.607
Return on Equity (MRQ)Greater than0.150.051
Return on Assets (MRQ)Greater than0.050.032
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Eris Lifesciences Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.335
Ma 20Greater thanMa 50858.660
Ma 50Greater thanMa 100865.738
Ma 100Greater thanMa 200883.562
OpenGreater thanClose882.000
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in INR. All numbers in thousands.

Summary
Total Assets38,751,880
Total Liabilities14,636,200
Total Stockholder Equity24,115,680
 As reported
Total Liabilities 14,636,200
Total Stockholder Equity+ 24,115,680
Total Assets = 38,751,880

Assets

Total Assets38,751,880
Total Current Assets9,611,510
Long-term Assets29,140,370
Total Current Assets
Cash And Cash Equivalents 1,727,140
Short-term Investments 168,260
Net Receivables 3,497,490
Inventory 1,390,890
Other Current Assets 2,776,200
Total Current Assets  (as reported)9,611,510
Total Current Assets  (calculated)9,559,980
+/- 51,530
Long-term Assets
Property Plant Equipment 4,224,630
Goodwill 3,318,490
Intangible Assets 18,236,070
Other Assets 3,151,830
Long-term Assets  (as reported)29,140,370
Long-term Assets  (calculated)28,931,020
+/- 209,350

Liabilities & Shareholders' Equity

Total Current Liabilities4,971,380
Long-term Liabilities9,504,770
Total Stockholder Equity24,115,680
Total Current Liabilities
Short Long Term Debt 1,888,610
Accounts payable 1,505,250
Other Current Liabilities 221,380
Total Current Liabilities  (as reported)4,971,380
Total Current Liabilities  (calculated)3,615,240
+/- 1,356,140
Long-term Liabilities
Long term Debt Total 6,324,730
Capital Lease Obligations Min Short Term Debt436,050
Long-term Liabilities Other 110,900
Long-term Liabilities  (as reported)9,504,770
Long-term Liabilities  (calculated)6,871,680
+/- 2,633,090
Total Stockholder Equity
Common Stock136,020
Retained Earnings 23,979,660
Total Stockholder Equity (as reported)24,115,680
Total Stockholder Equity (calculated)24,115,680
+/-0
Other
Capital Stock136,020
Cash and Short Term Investments 1,895,400
Common Stock Shares Outstanding 136,023
Liabilities and Stockholders Equity 38,751,880
Net Debt 6,131,850
Net Invested Capital 31,974,670
Net Working Capital 4,640,130
Property Plant and Equipment Gross 4,224,630



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-03-312021-09-302021-03-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
0
0
0
0
16,846,930
18,347,800
20,517,440
22,721,390
28,691,370
0
36,673,280
0
38,751,880
38,751,880036,673,280028,691,37022,721,39020,517,44018,347,80016,846,9300000
   > Total Current Assets 
5,314,550
0
4,796,170
0
5,997,260
4,670,460
5,223,930
6,273,300
6,154,360
0
7,647,220
0
9,611,510
9,611,51007,647,22006,154,3606,273,3005,223,9304,670,4605,997,26004,796,17005,314,550
       Cash And Cash Equivalents 
0
0
0
0
0
0
426,710
508,700
677,110
0
560,220
0
1,727,140
1,727,1400560,2200677,110508,700426,710000000
       Short-term Investments 
0
0
0
0
0
982,300
1,046,330
1,670,360
8,770
0
307,860
0
168,260
168,2600307,86008,7701,670,3601,046,330982,30000000
       Net Receivables 
1,408,280
0
2,069,080
0
1,945,890
1,404,880
1,602,120
1,609,680
3,004,640
0
4,583,910
0
3,497,490
3,497,49004,583,91003,004,6401,609,6801,602,1201,404,8801,945,89002,069,08001,408,280
       Inventory 
720,910
0
694,750
0
902,670
944,660
1,031,420
1,179,110
1,085,190
0
1,314,350
0
1,390,890
1,390,89001,314,35001,085,1901,179,1101,031,420944,660902,6700694,7500720,910
       Other Current Assets 
703,740
0
551,480
0
1,087,960
936,110
1,049,870
1,075,420
1,354,940
0
715,840
0
2,776,200
2,776,2000715,84001,354,9401,075,4201,049,870936,1101,087,9600551,4800703,740
   > Long-term Assets 
0
0
0
0
0
0
15,293,510
16,448,090
22,537,010
0
29,026,060
0
29,140,370
29,140,370029,026,060022,537,01016,448,09015,293,510000000
       Property Plant Equipment 
951,040
0
872,790
0
778,680
778,780
1,404,300
1,918,570
2,994,150
0
3,773,790
0
4,224,630
4,224,63003,773,79002,994,1501,918,5701,404,300778,780778,6800872,7900951,040
       Goodwill 
0
0
0
0
934,740
934,740
934,740
934,740
3,378,620
0
3,318,490
0
3,318,490
3,318,49003,318,49003,378,620934,740934,740934,740934,7400000
       Intangible Assets 
0
0
0
0
6,907,790
6,840,760
6,691,740
6,595,980
12,874,370
0
18,805,960
0
18,236,070
18,236,070018,805,960012,874,3706,595,9806,691,7406,840,7606,907,7900000
       Long-term Assets Other 
0
0
0
0
0
0
48,950
243,430
372,800
0
189,790
0
200,800
200,8000189,7900372,800243,43048,950000000
> Total Liabilities 
0
0
0
0
2,667,430
2,583,590
3,261,700
3,638,280
8,422,000
0
14,713,400
0
14,636,200
14,636,200014,713,40008,422,0003,638,2803,261,7002,583,5902,667,4300000
   > Total Current Liabilities 
1,388,150
0
1,646,900
0
1,738,150
1,669,310
1,986,540
1,996,460
3,598,480
0
4,432,330
0
4,971,380
4,971,38004,432,33003,598,4801,996,4601,986,5401,669,3101,738,15001,646,90001,388,150
       Short-term Debt 
0
0
0
0
1,500
100
100
110
1,325,740
0
0
0
0
00001,325,7401101001001,5000000
       Short Long Term Debt 
0
0
0
0
0
0
100
110
1,325,740
0
1,855,690
0
1,888,610
1,888,61001,855,69001,325,740110100000000
       Accounts payable 
729,480
0
1,000,510
0
0
0
1,167,820
1,177,740
1,165,700
0
1,247,690
0
1,505,250
1,505,25001,247,69001,165,7001,177,7401,167,8200001,000,5100729,480
       Other Current Liabilities 
436,400
0
306,130
0
0
0
213,630
152,370
969,370
0
812,580
0
221,380
221,3800812,5800969,370152,370213,630000306,1300436,400
   > Long-term Liabilities 
0
0
0
0
0
0
1,275,140
1,642,900
4,520,960
0
10,034,180
0
9,504,770
9,504,770010,034,18004,520,9601,642,9001,275,140000000
       Long term Debt Total 
0
0
0
0
0
44,470
399,730
803,940
1,227,550
0
6,834,210
0
6,324,730
6,324,73006,834,21001,227,550803,940399,73044,47000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-1,500
-100
443,220
393,850
-867,040
0
466,950
0
436,050
436,0500466,9500-867,040393,850443,220-100-1,5000000
       Long-term Liabilities Other 
0
0
0
0
0
0
24,650
22,820
124,960
0
113,220
0
110,900
110,9000113,2200124,96022,82024,650000000
> Total Stockholder Equity
0
0
0
0
14,179,500
15,764,210
17,255,740
19,083,110
20,269,370
0
21,959,880
0
24,115,680
24,115,680021,959,880020,269,37019,083,11017,255,74015,764,21014,179,5000000
   Retained Earnings 
0
0
12,797,280
0
14,043,720
15,628,430
17,119,830
18,947,180
20,133,380
0
21,559,300
0
23,979,660
23,979,660021,559,300020,133,38018,947,18017,119,83015,628,43014,043,720012,797,28000
   Accumulated Other Comprehensive Income 0000000000000
   Capital Surplus 0000000000000
   Treasury Stock0000000000000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue17,749,810
Cost of Revenue-3,392,590
Gross Profit14,357,22014,357,220
 
Operating Income (+$)
Gross Profit14,357,220
Operating Expense-13,133,020
Operating Income4,616,7901,224,200
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense13,133,0200
 
Net Interest Income (+$)
Interest Income-
Interest Expense-455,200
Other Finance Cost-21,220
Net Interest Income-433,980
 
Pretax Income (+$)
Operating Income4,616,790
Net Interest Income-433,980
Other Non-Operating Income Expenses-
Income Before Tax (EBT)4,211,6004,616,790
EBIT - interestExpense = -455,200
3,855,620
4,310,820
Interest Expense455,200
Earnings Before Interest and Taxes (EBIT)-4,666,800
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax4,211,600
Tax Provision-434,900
Net Income From Continuing Ops3,776,7003,776,700
Net Income3,855,620
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-433,980
 

Technical Analysis of Eris
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Eris. The general trend of Eris is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Eris's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Eris Lifesciences Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 940.75 < 960.90 < 962.50.

The bearish price targets are: 865.20 > 831.00 > 825.00.

Tweet this
Eris Lifesciences Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Eris Lifesciences Ltd. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Eris Lifesciences Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Eris Lifesciences Ltd. The current macd is 6.06977694.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Eris price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Eris. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Eris price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Eris Lifesciences Ltd Daily Moving Average Convergence/Divergence (MACD) ChartEris Lifesciences Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Eris Lifesciences Ltd. The current adx is 19.08.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Eris shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Eris Lifesciences Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Eris Lifesciences Ltd. The current sar is 814.88.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Eris Lifesciences Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Eris Lifesciences Ltd. The current rsi is 63.33. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Eris Lifesciences Ltd Daily Relative Strength Index (RSI) ChartEris Lifesciences Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Eris Lifesciences Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Eris price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Eris Lifesciences Ltd Daily Stochastic Oscillator ChartEris Lifesciences Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Eris Lifesciences Ltd. The current cci is 153.70.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Eris Lifesciences Ltd Daily Commodity Channel Index (CCI) ChartEris Lifesciences Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Eris Lifesciences Ltd. The current cmo is 41.20.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Eris Lifesciences Ltd Daily Chande Momentum Oscillator (CMO) ChartEris Lifesciences Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Eris Lifesciences Ltd. The current willr is -5.32212885.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Eris Lifesciences Ltd Daily Williams %R ChartEris Lifesciences Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Eris Lifesciences Ltd.

Eris Lifesciences Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Eris Lifesciences Ltd. The current atr is 23.83.

Eris Lifesciences Ltd Daily Average True Range (ATR) ChartEris Lifesciences Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Eris Lifesciences Ltd. The current obv is -4,224,666.

Eris Lifesciences Ltd Daily On-Balance Volume (OBV) ChartEris Lifesciences Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Eris Lifesciences Ltd. The current mfi is 71.01.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Eris Lifesciences Ltd Daily Money Flow Index (MFI) ChartEris Lifesciences Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Eris Lifesciences Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.

6.3. Candlestick Patterns

Eris Lifesciences Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Eris Lifesciences Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.335
Ma 20Greater thanMa 50858.660
Ma 50Greater thanMa 100865.738
Ma 100Greater thanMa 200883.562
OpenGreater thanClose882.000
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Eris with someone you think should read this too:
  • Are you bullish or bearish on Eris? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Eris? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Eris Lifesciences Ltd

I send you an email if I find something interesting about Eris Lifesciences Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Eris Lifesciences Ltd.

Receive notifications about Eris Lifesciences Ltd in your mailbox!